14159 capital (GP), LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for 14159 capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of 14159 capital (GP), LLC. 14159 capital (GP), LLC is a Director in INCYTE CORP ($INCY) and a 10% Owner in PHARMACYCLICS INC ($PCYC) and a 10% Owner in VIROPHARMA INC ($VPHM) and a Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and a 10% Owner in ADOLOR CORP ($ADLR) and a Director in Ardea Biosciences, Inc./DE ($IBPI) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX) and a 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL) and a 10% Owner in Ocera Therapeutics, Inc. ($TZYM).
Address: 667 MADISON AVENUE, 21ST FLOOR NEW YORK US 10065 NY
Companies in which 14159 capital (GP), LLC is an Insider
ADOLOR CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Jan 03 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ardea Biosciences, Inc./DE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of 14159 capital (GP), LLC: Director
Holdings: 116,454 shares
Latest Transaction: Feb 03 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AUXILIUM PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 132,889 shares
Latest Transaction: Aug 03 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOMIC HEALTH INC
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of 14159 capital (GP), LLC: Director
Holdings: 227,840 shares
Current Value: $6,263,322
Latest Transaction: Mar 09 2012
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INCYTE CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of 14159 capital (GP), LLC: Director
Holdings: 355,839 shares
Current Value: $42,053,053
Latest Transaction: Jan 17 2012
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ocera Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 57,704 shares
Latest Transaction: Mar 14 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PHARMACYCLICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 195,858 shares
Latest Transaction: Jan 26 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of 14159 capital (GP), LLC: Director
Holdings: 323,148 shares
Current Value: $19,644,167
Latest Transaction: Sep 08 2011
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of 14159 capital (GP), LLC: Director
Holdings: 135,739 shares
Latest Transaction: Jan 09 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VIROPHARMA INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 303,264 shares
Latest Transaction: Dec 16 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of 14159 capital (GP), LLC
Sentiment: All, ADLR, IBPI, AUXL, GHDX, INCY, TZYM, PCYC, SGEN, GEVA, VPHM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 3.01 | 910 | 2,735 | 57,704 | 56.8 K to 57.7 K (+1.60 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 2.99 | 1,482 | 4,430 | 56,794 | 55.3 K to 56.8 K (+2.68 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 2.96 | 4,186 | 12,383 | 55,312 | 51.1 K to 55.3 K (+8.19 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 2.55 | 15,076 | 38,444 | 51,126 | 36.1 K to 51.1 K (+41.82 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 2.34 | 8,628 | 20,186 | 36,050 | 27.4 K to 36.1 K (+31.46 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 1.87 | 1,170 | 2,188 | 27,422 | 26.3 K to 27.4 K (+4.46 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 1.89 | 430 | 811 | 26,252 | 25.8 K to 26.3 K (+1.67 %) |